| Financial Year |
March 31 2023 |
| Monetary Funds |
1,291,325,552.72 |
| Held-for-trading Financial Assets |
117,310.11 |
| Notes Receivable |
55,781,952.35 |
| Accounts Receivable |
1,917,105,230.41 |
| Advances to Suppliers |
178,149,285.05 |
| Other Receivables |
801,407,720.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,647,972,100.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
185,963,091.38 |
| Total Current Assets |
7,122,767,014.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,748,542,877.67 |
| Fixed Assetes |
3,673,484,136.65 |
| Under-construction Projects |
216,552,801.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
785,465.17 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
518,206,969.87 |
| R&D expenses |
-- |
| Goodwill |
106,350,551.22 |
| Long-Term Deferred and Prepaid Expenses |
81,351,891.45 |
| Deferred Income Tax Assets |
95,901,705.57 |
| Other Non-Current Assets |
14,411,627.87 |
| Sub-Total of Non-Current Assets |
7,678,038,843.98 |
| Total Assets |
14,800,805,858.96 |
| Short-Term Loans |
26,009,225.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
35,240,876.68 |
| Accounts Payable |
2,216,538,679.18 |
| Accounts Received In Advance |
63,306,530.50 |
| Employee Compensation Payable |
174,075,763.26 |
| Taxes Payable |
984,880,383.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,338,167,322.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,103,861.27 |
| Other Current Liabilities |
85,321,409.97 |
| Sub-Total of Current Liabilities |
5,157,359,239.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
842,705,214.88 |
| Special Payable |
-- |
| Estimatied Liabilities |
979,811,157.25 |
| Deferred Income Tax Liabilities |
54,991,269.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,713,114,430.66 |
| Total Liabilities |
7,870,473,670.43 |
| Paid-In Capital(Or Share Stock) |
13,863,866,690.00 |
| Capital Surplus |
18,782,884,741.70 |
| Surplus Reserve |
1,525,575,798.27 |
| LESS:Treasury Stock |
1,222,087,272.10 |
| Undistributed Profits |
-26,053,816,537.39 |
| Minority Stockholder's Interest |
32,477,721.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,897,854,467.42 |
| Owner's Equity（Stockholder's Equity） |
6,930,332,188.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,800,805,858.96 |
